STRONGBRIDGE BIOPHARMA plc Proceeds from Stock Options Exercised
STRONGBRIDGE BIOPHARMA plc reported Proceeds from Stock Options Exercised of $138.00 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2021-08-05
- STRONGBRIDGE BIOPHARMA plc proceeds from stock options exercised for the quarter ending 2021-06-30 was $0.00.
- STRONGBRIDGE BIOPHARMA plc proceeds from stock options exercised for the quarter ending 2021-03-31 was $138.00K.
- STRONGBRIDGE BIOPHARMA plc proceeds from stock options exercised for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- STRONGBRIDGE BIOPHARMA plc proceeds from stock options exercised for the quarter ending 2019-09-30 was -$1.00K, a 105.00% decline year-over-year.
- STRONGBRIDGE BIOPHARMA plc proceeds from stock options exercised for fiscal 2019 was $179.00K, a 86.46% increase from fiscal 2018.
- STRONGBRIDGE BIOPHARMA plc proceeds from stock options exercised for fiscal 2018 was $96.00K, a 84.66% decline from fiscal 2017.
- STRONGBRIDGE BIOPHARMA plc proceeds from stock options exercised for fiscal 2017 was $626.00K, a 421.67% increase from fiscal 2016.
- STRONGBRIDGE BIOPHARMA plc proceeds from stock options exercised for fiscal 2016 was $120.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $138.00K 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | $138.00K 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$1.00K derived: sum of 2 quarters · filed 2021-03-03 | $13.00K derived: sum of 3 quarters · filed 2021-03-03 | $179.00K 10-K · filed 2021-03-03 |
| 2019-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $13.00K derived: sum of 2 quarters · filed 2020-10-29 | $179.00K 10-Q · filed 2020-10-29 | $196.00K derived: sum of 4 quarters · filed 2021-03-03 |
| 2019-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $180.00K 10-Q · filed 2020-08-04 | $197.00K derived: sum of 3 quarters · filed 2021-03-03 | $217.00K derived: sum of 4 quarters · filed 2021-03-03 |
| 2019-03-31 | $166.00K 10-Q · filed 2020-05-06 | $183.00K derived: sum of 2 quarters · filed 2021-03-03 | $203.00K derived: sum of 3 quarters · filed 2021-03-03 | $203.00K derived: sum of 4 quarters · filed 2021-03-03 |
| 2018-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $37.00K derived: sum of 2 quarters · filed 2021-03-03 | $37.00K derived: sum of 3 quarters · filed 2021-03-03 | $96.00K 10-K · filed 2021-03-03 |
| 2018-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $20.00K derived: sum of 2 quarters · filed 2019-11-07 | $79.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $59.00K 10-Q · filed 2019-07-31 | ||
| 2018-03-31 | $59.00K 10-Q · filed 2019-05-01 | |||
| 2017-12-31 | $626.00K 10-K · filed 2020-02-28 | |||
| 2016-12-31 | $120.00K 10-K · filed 2019-02-27 |